Legislative Activity

The Critical Materials Future Act of 2025 aims to bolster the domestic processing of critical materials by establishing a pilot program that utilizes innovative financial tools to support at least three domestic projects. This program seeks to stabilize financial aspects, attract private investment, and secure U.S. supply chains, while also studying the impact of these financial tools on the critical materials market. The Act prioritizes projects that enhance U.S. security, economic competitiveness, and sustainability, with a focus on mitigating risks from foreign entities and promoting domestic feedstock and offtake agreements. It also establishes a Critical Materials Revolving Fund to reinvest revenues and requires annual reports to Congress on the program's progress and recommendations.

The Insure Cybersecurity Act of 2025 establishes a Working Group on Cyber Insurance, chaired by the Assistant Secretary of Commerce for Communications and Information. This group is tasked with studying the cyber insurance market to make coverage clearer, more accessible, and more affordable for consumers and businesses. After delivering a final report with recommendations to Congress, the Working Group will dissolve, and the Assistant Secretary will publicly disseminate the resulting informative resources.

The "Skinny Labels, Big Savings Act" aims to reduce drug costs by clarifying that generic drug manufacturers are not infringing on patents when seeking FDA approval for a use of a drug that is no longer covered by patent ("skinny label"). The bill amends patent law to create a safe harbor for generic drug manufacturers who seek FDA approval for a drug with a label that excludes any uses still covered by patents. This exemption extends to the promotion and marketing of the drug, as long as it does not reference the patented condition of use. The bill also includes similar provisions for biosimilar biological products.